Covid

China’s Zero-Covid Rules ‘Buy Time’ for 49m Unvaccinated Elderly

 

China’s strict zero-Covid rules are helping to buy time to boost vaccination rates among the elderly and create new treatments, making them essential to overcome the pandemic, senior health advisers wrote in recently published reports.

In correspondence published by peer-reviewed medical journal the Lancet last Friday, a team of city medical experts said Shanghai’s vital role in the national economy made lockdown unavoidable.

Shanghai, a city of 25 million people, has been locked down for nearly six weeks as it battles China’s biggest coronavirus outbreak, but the government have shrugged off criticism of its zero-Covid strategy, saying it remains the best option.

“As a leading economic centre and an open city in China, Shanghai has huge exchanges with other cities and regions in the country, so the spill-out of virus to other places… could have unimaginably severe consequences,” said the team, which includes Zhang Wenhong, an adviser to authorities in Shanghai on treatment for Covid-19.

 

ALSO SEE: Easing ‘Zero Covid’ Policy Could Cause 2m Deaths: China Study

 

 

49 Million Elderly Unvaccinated

Shanghai’s “dynamic” zero-Covid policies would “overcome weak links in the immunological barrier in populations across the country”, they said, pointing out that around 49 million people aged 60 and over were still unvaccinated.

New vaccines specifically targeting Omicron variants could be available soon, but China also needed to overcome vaccine hesitancy, especially among old and vulnerable people, they added.

Dynamic zero-Covid was still required to prevent a “run” on China’s health resources, according to a separate commentary published in the official journal of China’s Disease Prevention and Control Center and cowritten by senior government health advisor Liang Wannian.

“The dynamic Covid-zero strategies adopted by China have won a precious time window for the future,” it said, adding that the country must “seize the opportunity” to develop more drugs and vaccines.

 

  • Reuters with additional editing by Jim Pollard

 

ALSO READ:

 

Asian Stocks Retreat as China Covid Fears, Inflation Weigh

 

China Covid Crackdown Hits Firms From Tesla to Taco Bell

 

Foxconn Shifts Operations from Kunshan To Avoid China Covid Hit

 

 

Jim Pollard

Jim Pollard is an Australian journalist based in Thailand since 1999. He worked for News Ltd papers in Sydney, Perth, London and Melbourne before travelling through SE Asia in the late 90s. He was a senior editor at The Nation for 17+ years and has a family in Bangkok.

Recent Posts

Hang Seng Gains on Tech Earnings, Nikkei Up as BoJ Stands Firm

Google-owner Alphabet and Microsoft posted better-than-expected quarterly results while big funds upgraded their outlook for Chinese…

12 mins ago

China Voices Concern on ‘Negative Factors’ in Dealings With US

Wang warns of all kinds of disruptions rocking bilateral ties, with China's "legitimate development rights"…

1 hour ago

EV Battery-Maker CATL Unveils Single-Charge 1,000km Power Unit

CATL showed off the lithium iron phosphate (LFP) Shenxing Plus battery on the first media…

18 hours ago

Blinken Urges China to Play Fair With American Companies

The US Secretary of State is in Shanghai as the two superpowers continue to defrost…

19 hours ago

China Unveils Brain Chip Similar to Elon Musk’s Neuralink

China says its fully homegrown brain-computer interface was tested on a monkey, allowing it to…

21 hours ago

TikTok Vows ‘We Will Fight’ After Biden Signs Sale Order

After Biden's swift presidential endorsement, attention is now turning to whether TikTok can win a…

21 hours ago